Adverse Effects of Combination Angiotensin II Receptor Blockers Plus Angiotensin-Converting Enzyme Inhibitors for Left Ventricular Dysfunction | Zendy

Christopher O. Phillips | Zendy; Amir Kashani | Zendy; Dennis T. Ko | Zendy; Gary L. Francis | Zendy; Harlan M. Krumholz | Zendy

Open Access

Adverse Effects of Combination Angiotensin II Receptor Blockers Plus Angiotensin-Converting Enzyme Inhibitors for Left Ventricular Dysfunction

Author(s) -

Christopher O. Phillips,

Amir Kashani,

Dennis T. Ko,

Gary L. Francis,

Harlan M. Krumholz

Publication year - 2007

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.167.18.1930

Subject(s) - medicine , adverse effect , hyperkalemia , renal function , angiotensin converting enzyme , creatinine , confidence interval , relative risk , myocardial infarction , heart failure , cardiology , blood pressure

We performed a meta-analysis of randomized controlled trials to assess ongoing concerns about the safety profile of combination angiotensin II receptor blockers (ARBs) plus angiotensin-converting enzyme (ACE) inhibitors in symptomatic left ventricular dysfunction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research